Advertisement

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Current Issue

2014: 112/2 (Aug) pp. 223-426

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

24 articles
1.

Insight on Willecke et al.

E. Lutgens (1, 2)

(1) Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University (LMU), Munich, Germany; (2) Dept of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

Thromb Haemost 2014 112 2: 223-223

http://dx.doi.org/10.1160/TH14-07-0583

[Summary] [Free PDF] [Export citation]
2.

P. Adamski (1), M. Koziński (1), M. Ostrowska (1), T. Fabiszak (2), E. P. Navarese (2), P. Paciorek (3), G. Grześk (2, 4), J. Kubica (2)

(1) Department of Principles of Clinical Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; (2) Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; (3) Department of Emergency Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; (4) Department of Pharmacology and Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

Thromb Haemost 2014 112 2: 224-242

http://dx.doi.org/10.1160/TH13-11-0915

[Summary] [Free PDF] [Export citation]
3.

Online Supplementary Material

E. K. O. Kruithof (1), S. Dunoyer-Geindre (1)

(1) Division of Angiology and Hemostasis, Department of Internal Medicine, University Hospital of Geneva and Faculty of Medicine of the University of Geneva, Geneva, Switzerland

Thromb Haemost 2014 112 2: 243-254

http://dx.doi.org/10.1160/TH13-06-0517

[Summary] [Free PDF] [Export citation]
4.

Online Supplementary Material

C. Martinez (1), A. T. Cohen (2), L. Bamber (3), S. Rietbrock (1)

(1) Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany; (2) Department of Thrombosis and Haemostasis, Guy's & St. Thomas' Hospital NHS FT, London, UK; (3) Bayer Pharma AG, Wuppertal, Germany

Thromb Haemost 2014 112 2: 255-263

http://dx.doi.org/10.1160/TH13-09-0793

[Summary] [Free PDF] [Export citation]
5.

Online Supplementary Material

G. You (1, 2), K. Chi (1), Y. Lu (3), Q. Ding (3), J. Dai (3), X. Xi (1), H. Wang (1), X. Wang (3)

(1) State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine; (2) Department of Laboratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine; (3) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Thromb Haemost 2014 112 2: 264-270

http://dx.doi.org/10.1160/TH13-10-0892

[Summary] [PDF] [Export citation]
6.

M. Ninivaggi (1), H. Kelchtermans (1), M. J. Kuijpers (2), B. Hemmeryckx (3), J. W. M. Heemskerk (2), T. Lindhout (1), M. F. Hoylaerts (3), B. de Laat (1, 2)

(1) Synapse BV, CARIM, Maastricht University Medical Centre, Maastricht, The Netherlands; (2) Biochemistry, CARIM, Maastricht University Medical Centre, Maastricht, The Netherlands; (3) Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

Thromb Haemost 2014 112 2: 271-275

http://dx.doi.org/10.1160/TH13-11-0910

[Summary] [PDF] [Export citation]
7.

Online Supplementary Material

C. Martinez (1), A. Katholing (1), S. B. Freedman (2)

(1) Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany; (2) Department of Cardiology Concord Hospital and Anzac Research Institute, Sydney Medical School, University of Sydney, Australia

Thromb Haemost 2014 112 2: 276-286

http://dx.doi.org/10.1160/TH4-04-0383

[Summary] [PDF] [Export citation]
8.

M. Celińska-Lowenhoff (1), T. Iwaniec (1), A. Padjas (1), J. Musiał (1), A. Undas (2)

(1) Department of Medicine, Jagiellonian University Medical College, Krakow, Poland; (2) Institute of Cardiology Jagiellonian University Medical College, and John Paul II Hospital, Krakow, Poland

Thromb Haemost 2014 112 2: 287-296

http://dx.doi.org/10.1160/TH13-11-0980

[Summary] [PDF] [Export citation]
9.

I. Mancini (1), C. Valsecchi (1), L. A. Lotta (1), L. Deforche (2), S. Pontiggia (1), M. Bajetta (1), R. Palla (1), K. Vanhoorelbeke (2), F. Peyvandi (1)

(1) Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, Università degli Studi di Milano and Luigi Villa Foundation, Milan, Italy; (2) Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven KULAK, Kortrijk, Belgium

Thromb Haemost 2014 112 2: 297-303

http://dx.doi.org/10.1160/TH13-08-0688

[Summary] [PDF] [Export citation]
10.

A. M. Schut (1), A. Hyseni (2), J. Adelmeijer (1), J. C. M. Meijers (3), P. G. De Groot (2), T. Lisman (1)

(1) Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; (2) Department of Clinical Chemistry and Haematology, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands; (3) Departments of Experimental Vascular Medicine and Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands

Thromb Haemost 2014 112 2: 304-310

http://dx.doi.org/10.1160/TH13-09-0798

[Summary] [PDF] [Export citation]
11.
Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients
High on-treatment platelet reactivity analysis of the TRIPLET trial

J. G. Diodati (1), J. F. Saucedo (2), T. E. Cardillo (3), J. A. Jakubowski (3), C. Henneges (4), M. B. Effron (3), F. R. Lipkin (5), J. R. Walker (5), S. Duvvuru (3), S. S. Sundseth (6), H. N. Fisher (7), D. J. Angiolillo (8)

(1) Division of Cardiology, Hopital du Sacre-Coeur de Montreal, Montreal, Quebec, Canada; (2) Division of Cardiology, NorthShore University Health System, Evanston, Illinois, USA; (3) Eli Lilly and Company, Indianapolis, Indiana, USA; (4) Eli Lilly and Company, Bad Homburg, Germany; (5) Daiichi Sankyo, Inc., Parsippany, New Jersey, USA; (6) Cabernet Pharmaceuticals, Inc., Durham, North Carolina, USA; (7) Eli Lilly and Company, Toronto, Ontario, Canada; (8) Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thromb Haemost 2014 112 2: 311-322

http://dx.doi.org/10.1160/TH13-09-0747

[Summary] [PDF] [Export citation]
12.

K. P. Bliden (1), A. Singla (2), M. G. Gesheff (1), P. P. Toth (3), A. Tabrizchi (1), G. Ens (1), K. Guyer (4), M. Singh (1), C. J. Franzese (1), D. Stapleton (5), U. S. Tantry (1), P. A. Gurbel (1)

(1) Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, Maryland, USA; (2) Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; (3) Department of Preventative Cardiology, CGH Medical Center, Sterling, Illinois, USA; (4) Department of Chemistry, Indiana University South Bend, South Bend, Indiana, USA; (5) Department of Medicine, Guthrie/Robert Packer Hospital, Sayre, Pennsylvania, USA

Thromb Haemost 2014 112 2: 323-331

http://dx.doi.org/10.1160/TH14-01-0094

[Summary] [PDF] [Export citation]
13.

Online Supplementary Material

A. Assinger (1, 2), Y. Wang (2, 3), L. M. Butler (2), G. K. Hansson (2), Z.-q. Yan (2), C. Söderberg-Nauclér (2), D. F. J. Ketelhuth (2)

(1) Institute of Physiology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria; (2) Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden; (3) Department of Geriatrics, Qilu Hospital, Shandong University, Jinan, China

Thromb Haemost 2014 112 2: 332-341

http://dx.doi.org/10.1160/TH13-12-1026

[Summary] [PDF] [Export citation]
14.

Online Supplementary Material

K. Mayer (1), S. Schulz (1), I. Bernlochner (2), T. Morath (1), S. Braun (1), J. Hausleiter (3), S. Massberg (3), H. Schunkert (1, 4), K.-L. Laugwitz (2, 4), A. Kastrati (1, 4), D. Sibbing (3, 4)

(1) Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; (2) I. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; (3) Department of Cardiology, Ludwig-Maximilians-Universität, Munich, Germany; (4) DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany

Thromb Haemost 2014 112 2: 342-351

http://dx.doi.org/10.1160/TH13-10-0874

[Summary] [PDF] [Export citation]
15.

M. Michels (1), B. Alisjahbana (2), P. G. De Groot (3), A. R. Indrati (4), R. Fijnheer (3), M. Puspita (2), I. M. W. Dewi (2), L. van de Wijer (1), E. M. S. de Boer (1), M. Roest (3), A. J. A. M. van der Ven (1), Q. de Mast (1)

(1) Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; (2) Department of Internal Medicine, Faculty of Medicine, University of Padjadjaran, Bandung, Indonesia; (3) Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands; (4) Department of Clinical Pathology, Faculty of Medicine, University of Padjadjaran, Bandung, Indonesia

Thromb Haemost 2014 112 2: 352-362

http://dx.doi.org/10.1160/TH14-01-0056

[Summary] [PDF] [Export citation]
16.

S. Lenglet (1), F. Montecucco (2, 3), F. Mach (1), K. Schaller (4, 5), Y. Gasche (5, 6), J.-C. Copin (1)

(1) Division of Cardiology, Foundation for Medical Researches, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland; (2) First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine. IRCCS Azienda Ospedaliera Universitaria San Martino–IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy; (3) Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; (4) Division of Neurosurgery, Department of Clinical Neurosciences, University Hospitals of Geneva, Geneva, Switzerland; (5) Geneva Neuroscience Center, University of Geneva, Geneva, Switzerland; 6 Division of Intensive Care, Department of Anaesthesiology, Pharmacology and Intensive Care, University Hospitals of Geneva, Geneva, Switzerland

Thromb Haemost 2014 112 2: 363-378

http://dx.doi.org/10.1160/TH14-01-0007

[Summary] [PDF] [Export citation]
17.

Online Supplementary Material

See also Insight by Lutgens

F. Willecke (1), S. Tiwari (1), B. Rupprecht (1), D. Wolf (1), S. Hergeth (1), N. Hoppe (1), B. Dufner (1), L. Schulte (1), N. Anto Michel (1), N. Bukosza (1), T. Marchini (1), M. Jäckel (1), P. Stachon (1), I. Hilgendorf (1), K. Zeschky (1), R. Schleicher (2), H. F. Langer (2), C. von zur Muhlen (1), C. Bode (1), K. Peter (3), A. Zirlik (1)

(1) Atherogenesis Research Group, Heart Center Freiburg University, Freiburg, Germany; (2) Department of Cardiovascular Medicine, University of Tübingen, Tübingen, Germany; (3) Baker IDI Heart and Diabetes Institute, Melbourne, Australia

Thromb Haemost 2014 112 2: 379-389

http://dx.doi.org/10.1160/TH13-08-0653

[Summary] [PDF] [Export citation]
18.

S. Morel (1, 2), M. Chanson (3), T. D. Nguyen (4), A. M. Glass (4), M. Z. Richani Sarieddine (3), M. J. Meens (1, 2), L. Burnier (1, 2), B. R. Kwak (1, 2), S. M. Taffet (4)

(1) Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; (2) Department of Internal Medicine – Division of Cardiology, University of Geneva, Geneva, Switzerland; (3) Laboratory of Clinical Investigation III, Department of Pediatrics, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; (4) Department of Microbiology, SUNY Upstate Medical University, Syracuse, New York, USA

Thromb Haemost 2014 112 2: 390-401

http://dx.doi.org/10.1160/TH13-09-0773

[Summary] [PDF] [Export citation]
19.

K. Gray (1), S. Elghadban (1), P. Thongyoo (2), K. A. Owen (1), R. Szabo (3), T. H. Bugge (3), E. W. Tate (2), R. J. Leatherbarrow (2), V. Ellis (1)

(1) School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK; (2) Biologicaland Biophysical Chemistry Section, Department of Chemistry, Imperial College London, UK; (3) Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA

Thromb Haemost 2014 112 2: 402-411

http://dx.doi.org/10.1160/TH13-11-0895

[Summary] [PDF] [Export citation]
20.

N. Vaezzadeh (1, 2), R. Ni (1, 2), P. Y. Kim (1, 3), J. I. Weitz (1, 2, 3, 4), P. L. Gross (1, 2, 3)

(1) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada; (2) Department of Medical Sciences, McMaster University, Hamilton, Canada; (3) Department of Medicine, McMaster University, Hamilton, Canada; (4) Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada

Thromb Haemost 2014 112 2: 412-418

http://dx.doi.org/10.1160/TH13-11-0919

[Summary] [PDF] [Export citation]
  1-20 21-24